Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.58 USD | +7.83% | +7.22% | +63.15% |
11:49am | Baird Initiates Enliven Therapeutics With Outperform Rating, $32 Price Target | MT |
May. 29 | Enliven Therapeutics, Inc. Appoints Lori Kunkel to the Committee | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+63.15% | 1.06B | |
+18.77% | 125B | |
+14.05% | 108B | |
-7.16% | 23.64B | |
+2.13% | 22.39B | |
-11.90% | 17.78B | |
-41.74% | 16.43B | |
-13.47% | 16.34B | |
+2.23% | 13.56B | |
+27.13% | 11.59B |
- Stock Market
- Equities
- ELVN Stock
- News Enliven Therapeutics, Inc.
- Enliven Therapeutics Q3 Loss Narrows